3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
HIV Infections
1
Interventions
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Vincristine
2
Vaccines
2
Rituximab
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Papillomavirus Vaccines
2
Mass Screening
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Etoposide
2
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
pandemrix
1
lactitol
1
halofantrine
1
focetria
1
fludarabine
1
efineptakin alfa
1
efavirenz
1
X-Rays
1
VAP-cyclo protocol
1
Triage
1
Transplantation Conditioning
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Surveys and Questionnaires
1
Standard of Care
1
Spirometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
HIV Infections
×
Nurse Clinicians
×
Clear all
NCT00466258
2009-11-25
LINFOTARGAM
PETHEMA Foundation
Phase 4
Completed
50 enrolled